| Pharmaceutical active ingredients: |
| Phenazone |
| Available forms, composition and doses of Oto-Phen: |
| N / A |
| Oto-Phen medical category: |
| Human:Analgesics and antipyretics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N02BB01 - PhenazoneS02DA03 - Phenazone |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Adcock Ingram |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Otopain | Fludrocortisone Acetate; Lidocaine Hydrochloride; Neomycin Sulfate; Polymyxin B Sulfate | Interbat |
| Otopax | Phenazone; Procaine Hydrochloride | Italiani Vaillant Laboratori |
| Oto-Ped | Fludrocortisone Acetate; Lidocaine Hydrochloride; Neomycin Sulfate; Nitrofurazone; Polymyxin B Sulfate | Stiefel Laboratories |
| Otopen | Chloramphenicol; Lidocaine Hydrochloride | Dinafarma Laboratorio |
| Otophen | Chloramphenicol | Unidentified Pharmaceutical Company |
| Oto-Phen Forte | Benzocaine; Ephedrine Hydrochloride; Phenazone; Potassium Hydroxyquinoline Sulfate | Adcock Ingram |
| Otopraf | Fludrocortisone Acetate; Lidocaine Hydrochloride; Neomycin Sulfate; Polymyxin B Sulfate | Prafa |
| Otopreven | Acetic Acid | Fortbenton Laboratorio Farmaceutico |
| Otoralgyl | Lidocaine Hydrochloride | Sanofi-Aventis; F. Uhlmann-Eyraud; Johnson & Johnson |
| Otoralgyl a la Phenylephrine | Lidocaine Hydrochloride; Phenylephrine Hydrochloride; Sodium Propionate | Johnson & Johnson |